Nothing in this article should be interpreted as guidance for human use, in line with MHRA regulations under the Human Medicines Regulations 2012
People who are obese (have a BMI greater than or equal to 30) are clinically eligible for GLP-1 drugs, but employer plans may set additional BMI requirements to cover GLP-1 drug use under obesity
In this blog, we will discuss the nature of hexarelin and sermorelin, similarities, differences, side effects, and the best choice
In summary: this report has provided an exhaustive examination of GLP-1 access via PBMs as of 2026, with data-backed insights into denial rates, timelines, and fill outcomes
If a vial would last 8 weeks at your dose, reconstitute with less water to create a higher concentration and use the vial faster, or use a smaller vial size